Roberto Bolli, MD, FAHA , Scientific Director
Roberto Bolli, M.D. is director of the Division of Cardiovascular Medicine and U of L’s Institute for Molecular Cardiology and the Scientific Director of the Cardiovascular Innovation Institute.
He is also Department Executive Vice Chairman and Vice Chair for Research in the Department of Medicine.
His research focuses on preventing the damage caused during heart attacks by studying ischemic preconditioning, the phenomenon in which heart muscle exposed to brief periods of stress becomes resistant to the tissue death that might be caused by a heart attack.
He is investigating the use of adult cardiac stem cells to repair dead heart tissue, pioneering the use of stem cells taken from the patient for potential heart repair applications.
He is currently chairman of the AHA’s Distinguished Scientist Selection Committee, of the AHA’s Council on Basic Cardiovascular Sciences and of the AHA’s Council Operations Committee. He is a member of the advisory council of the National Heart, Lung, and Blood Institute. He is also president of the International Society for Heart Research.
Bolli is the recipient of numerous awards and honors, including the Basic Research Prize of the American Heart Association (2001), the MERIT Award from the NIH (2001), the Research Achievement Award from the International Society for Heart Research (2004), the Lucian Award from McGill University (2004), the Ken Bowman Award from the University of Manitoba, and the Howard Morgan Award from the International Academy of Cardiovascular Sciences. He has published more than 270 peer-reviewed articles.